LENZ Therapeutics Inc (LENZ) Stock Analysis
Verdict: HOLD
Phase III commercialization potential is overshadowed by massive technical breakdown and a valuation gap vs DCF, despite a strong cash buffer.
Investment score: 42/100
Analysis as of
Is LENZ Therapeutics Inc stock worth reviewing? AI model thesis
The AI model rates LENZ as a HOLD. While early revenue beats and a robust cash position ($25.1M cash vs $21.5M total liabilities) provide a floor, the 89% drop from highs and the DCF valuation of $2.42 suggest the market is re-pricing the long-term commercial terminal value of the presbyopia pipeline.
7-factor investment score
- Valuation: 35/100 (weight 20%)
- Financial Health: 70/100 (weight 15%)
- Technical Momentum: 15/100 (weight 15%)
- Earnings Quality: 65/100 (weight 15%)
- Insider Sentiment: 60/100 (weight 10%)
- Analyst Consensus: 55/100 (weight 10%)
- Risk-Adjusted Return: 30/100 (weight 15%)
LENZ Therapeutics Inc opportunities and risks
What speaks for LENZ
- Significant Q2 Revenue Surprise
What speaks against LENZ
- Severe Technical Momentum Decay
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| LENZ | n/a | 7.6x | n/a | 90.1% | -586.7% | -70.0% |
| ANTX | n/a | 0.0x | n/a | 0.0% | 0.0% | -14.5% |
| SIGA | n/a | 3.8x | n/a | 54.3% | -5.1% | -9.9% |
| ORMP | 1.0x | 0.0x | 2.4x | 0.0% | 0.0% | -3.1% |
| DERM | n/a | 2.7x | n/a | 60.4% | -14.8% | -3.9% |
| Peer median | n/a | 1.3x | n/a | 27.2% | -2.6% | -6.9% |
Frequently asked questions about LENZ Therapeutics Inc (LENZ)
Is LENZ stock a good investment?
The cached TradeMates AI model rates LENZ Therapeutics Inc as HOLD with an investment score of 42/100. The AI model rates LENZ as a HOLD. While early revenue beats and a robust cash position ($25.1M cash vs $21.5M total liabilities) provide a floor, the 89% drop from highs and the DCF valuation of $2.42 suggest the market is re-pricing the long-term commercial terminal value of the presbyopia pipeline. This is algorithmic model output, not personal investment advice.
Is LENZ stock a buy?
The TradeMates model verdict for LENZ is HOLD with an investment score of 42/100. Treat this as a model signal to review, not a personal buy recommendation.